Building Biotechs

Recruitomics Consulting
Building Biotechs

From the ground floor to the C-Suite, Building Biotechs offers a behind-the-scenes look into the strategy that goes into launching and scaling successful biotech and life science companies. We talk with biotech executives, founders, HR leaders, and culture builders to learn how they think about growing companies with intention, and discuss the valuable lessons they’ve learned along the way.

  1. Funding, Partnerships, and Growth: Strategies for Startup Biotech Success with Fractional Chief Business Officer Renee Williams

    -2 ДН.

    Funding, Partnerships, and Growth: Strategies for Startup Biotech Success with Fractional Chief Business Officer Renee Williams

    This week I chatted with Renee Williams, Founder and Managing Partner at Williams Biotech Consulting. Renee is a seasoned fractional Chief Business Officer (CBO) for small and growing biotechnology companies. Renee shares her career path, insights into helping biotech startups secure funding and navigate partnerships, and the importance of adaptable strategies in a constantly evolving market. From term sheet negotiation to pitch deck reframes, Renee offers valuable advice and lessons for small companies. We also dissect her engagement tactics during major conferences like JP Morgan and the essential factors for biotech success. Get Renee's recommended book! The 3-Minute Rule: Say Less to Get More from Any Pitch or PresentationLink In with Renee! Connect with us! Link In with Carina Subscribe here: AppleSpotifyGoogle PodcastRSS feed Learn more about Recruitomics Consulting Check out our reading list Download our free startup resources guide to grow your biotech efficiently If you're on the job market, visit the Collaboratory Career Hub 00:00 Introduction and Childhood Dreams 01:19 The Power of Dressing the Part 01:49 Career Path and Consulting Firm 03:20 Role of a Fractional CBO 04:03 Navigating Startup Challenges 06:07 Crafting Effective Pitch Decks 08:32 Big Pharma vs. Biotech Mentality 16:01 The Importance of a Strong Team in Biotech 16:20 Approaching Pharma and Corporate Venture Capital 17:20 Strategies for Biotech Companies to Gain Traction 18:24 Types of Biotech CEOs and Their Approaches 21:02 Navigating Conferences and Networking 27:09 Future Goals and Aspirations 28:59 Book Recommendations and Closing Thoughts

    35 мин.
  2. Trust, Teamwork, and Innovation, with Natalie Nairn, Co-founder and CEO of Cyclera Therapeutics

    8 НОЯБ.

    Trust, Teamwork, and Innovation, with Natalie Nairn, Co-founder and CEO of Cyclera Therapeutics

    This week, I spoke with Natalie Nairn, co-founder and CEO of Cyclera Therapeutics. Natalie is also a Termeer Fellow, and listeners of this podcast know how much I love the Termeer Foundation. We discuss her transition from chemical engineering to biomedical applications. She describes her unexpected path into the fun and volatile startup space, which led to her founding Cyclera. Natalie explains the importance of focusing in biotech development, the promising applications of Cyclera's technology in CNS therapeutics, and the challenges and opportunities in the current funding landscape. She also highlights the value of the Termeer fellowship in her career, the contrast between Boston and Seattle's biotech scenes, and the essential aspects of leadership and team cohesion. Finally, Natalie discusses her future goals for Cyclera and offers valuable advice for aspiring biotech founders. Get Natalie's recommended book! The Book of Delights: EssaysCYpHER: catalytic extracellular targeted protein degradation with high potency and durable effect | Nature CommunicationsConnect with Natalie on LinkedIn!Learn more about Cyclera Therapeutics Connect with us! Link In with Carina Subscribe here: AppleSpotifyGoogle PodcastRSS feed Learn more about Recruitomics Consulting Check out our reading list Download our free startup resources guide to grow your biotech efficiently If you're on the job market, visit the Collaboratory Career Hub 00:00 Introduction and Early Aspirations 00:33 Journey into Biomedical Engineering 01:19 First Startup Experience 03:40 Founding Cyclera 05:02 Focus on CNS Therapeutics 13:35 Challenges and Strategies in Biotech 15:39 The Termeer Foundation Fellowship 21:26 Biotech Networks: Boston vs. Seattle 26:50 Future of Cyclera and Personalized Medicine 32:45 Conclusion and Final Thoughts

    38 мин.
  3. The Science of Success: Transforming Scientific Concepts into Marketable Products with Stacy Frye, co-founder and CCO of Stimulus Bio

    30 ОКТ.

    The Science of Success: Transforming Scientific Concepts into Marketable Products with Stacy Frye, co-founder and CCO of Stimulus Bio

    In this episode, I had an engaging conversation with Stacie Frye, co-founder and Chief Commercial Officer of StimulusBio, a life sciences commercialization and venture studio for biotech startups. We discussed how StimulusBio aids startups in operational and commercialization aspects, leveraging Stacie's unique journey across marketing, chemical engineering, and her experience with successful biotech exits. Experience from previous startups profoundly informs StimulusBio’s approach to helping startups transition from incubation to market. We explored the critical stages of startup growth, emphasizing the importance of marketing, storytelling, team building, and experience-based advice. Stacie also shared her insights into the emerging trends in the biotech industry, particularly in Houston's growing biotech ecosystem, and the importance of balancing innovation with practical business needs. Get Stacie's recommended book! Think Again: The Power of Knowing What You Don't KnowLearn about StimulusBioConnect with Stacie on LinkedIn! Connect with us! Link In with Carina Subscribe here: AppleSpotifyGoogle PodcastRSS feed Learn more about Recruitomics Consulting Check out our reading list Download our free startup resources guide to grow your biotech efficiently If you're on the job market, visit the Collaboratory Career Hub 00:00 Introduction to Stacie Frye and StimulusBio 00:51 Stacie's Unique Career Path 01:56 Early Career and Transition to Bioengineering 03:32 Startup Experiences and Lessons Learned 08:46 Challenges in Transitioning from Incubator to Market 12:44 The Importance of Marketing and Team Building 32:17 Emerging Trends and Future Goals 37:09 Conclusion and Contact Information

    40 мин.
  4. Small Offerings, Big Impact: Demystifying Micro-IPOs in Biotech with David Sans,  Head of Healthcare Investment Banking at EF Hutton

    11 ОКТ.

    Small Offerings, Big Impact: Demystifying Micro-IPOs in Biotech with David Sans, Head of Healthcare Investment Banking at EF Hutton

    This week, I had an insightful conversation with David Sans, PhD, FAARM, MBA, who heads healthcare investment banking at EF Hutton. We discussed the intricacies of different Public Offering strategies, including micro IPOs, which offer a unique avenue for biotech companies. David provides a deep perspective on the strategic implications of IPOs for biotech funding. He emphasized the importance of investor support and strategic banking partnerships, especially for micro IPOs. We also discussed the potential of AI in reshaping financial services and the future of outcome-based pricing models in investment. David's personal insights reveal the demanding yet rewarding nature of investment banking and highlight crucial aspects to consider for those pursuing a career in this field. Get David's recommended book: Barcelona, Catalonia: A View from the InsideLearn more about EF Hutton LLC!Link In with David! Connect with us! Link In with Carina Subscribe here: AppleSpotifyGoogle PodcastRSS feed Learn more about Recruitomics Consulting Check out our reading list Download our free startup resources guide to grow your biotech efficiently If you're on the job market, visit the Collaboratory Career Hub 00:00 Introduction to Biotech and Investment Banking 00:48 David Sands' Background and Career Journey 02:12 Transition from Biotech to Finance 04:53 Understanding Micro IPOs 06:37 Challenges and Strategies in Biotech IPOs 16:38 The Role of the FDA in Biotech IPOs 18:30 Understanding IPO Disparities 18:42 Key Factors for a Successful IPO 19:29 Aftermarket Support and Investor Relations 20:59 The Role of Long-Term Investors 21:34 Personal Investment Strategies 22:29 Innovations in Financial Services 24:40 Challenges for Biotech CEOs 26:32 Career Path in Investment Banking 28:50 Future of Financial Services and AI 33:37 Book Recommendations and Closing Thoughts

    37 мин.
  5. Not All Who Wander Are Lost: with Iva Toudjarska, founder and CEO of Zeal Therapeutics

    9 ОКТ.

    Not All Who Wander Are Lost: with Iva Toudjarska, founder and CEO of Zeal Therapeutics

    This week I had a great conversation with Iva Toudjarska, founder and CEO of Zeal Therapeutics. From earning a PhD in molecular biology to a solid scientific career at Alnylam, to working in venture capital, to selling a successful SaaS company, Iva’s career that’s set her up well to enjoy this new challenge – founding a baby biotech. Her expertise marries business development, venture capital, and company-building. Iva shared valuable advice for biotech founders on securing funding, making strategic decisions, and building effective partnerships. Tune in to hear her experiences, lessons learned, and her current work leading Zeal Therapeutics, a precision kidney RNA therapeutics company. Get Iva's favorite book! The AlchemistLink In with Iva! Connect with us! Link In with Carina Subscribe here: AppleSpotifyGoogle PodcastRSS feed Learn more about Recruitomics Consulting Check out our reading list Download our free startup resources guide to grow your biotech efficiently If you're on the job market, visit the Collaboratory Career Hub 00:00 - Intro to Iva Toudjarska's Career 00:48 - Career overview, Iva Toudjarska, Zeal Therapeutics 04:26 - Successful biotech strategies, industry insights 07:02 - Building successful partnerships, collaboration tips 12:15 - Angel investing, funding strategies, biotech financing 20:20 - Leveraging background, skills for biotech success 24:38 - Setbacks in biotech, lessons learned, resilience 27:20 - Bootstrapping a company, startup funding, entrepreneurship 28:23 - Support for Eva, mentorship, biotech advice 29:18 - Future goals, biotech vision, 10-year plan 30:45 - Current reading, professional development, industry literature 24:24 Lessons Learned and Future Goals 28:08 Conclusion and Final Thoughts

    33 мин.
  6. From Seed to Success: How MassBio is Boosting Biotech

    1 ОКТ.

    From Seed to Success: How MassBio is Boosting Biotech

    This week I had a fun conversation with Jason Cordeiro, Chief Operating and Innovation Officer at MassBio. We dissect MassBio's newly announced five-year strategic plan that includes a multi-pronged set of initiatives aimed at advancing the biotech industry. From supporting early-stage startups to advocating for policy changes and fostering talent development, Jason details the excellent resources available and in development. Whether you're based in Massachusetts or global, this session provides valuable information on how MassBio is working to catalyze innovation and growth in biotech, and how you can leverage these opportunities. 00:00 - Intro 01:24 - Jason Cordeiro, MassBio’s COO 02:48 - What is MassBio 05:54 - MassBio’s MassCONNECT Program 08:15 - MassCONNECT Support for Non-Local Companies 13:15 - How to Get Involved in MassBio 17:24 - Next Level One Initiative 19:58 - MassBio Align Summit Overview 21:40 - Educating Investors through MassBio 27:11 - MassBio Pharma Days Event 31:00 - The Link Program 34:54 - MassBio’s 5-Year Strategic Plan 41:14 - Connecting with MassBio Resources 42:11 - Outro Learn about Align Summit - MassBioLearn about Partnering Opportunities - MassBioLearn about the CEO & Founder Link - MassBioLearn about MassBio’s Vision 2030 strategic planLearn about MassBioDrive!Learn about MassBio InnovationLearn more about Massachusetts Biotechnology CouncilLinked In with Jason! Connect with us! Link In with Carina Subscribe here: AppleSpotifyGoogle PodcastRSS feed Learn more about Recruitomics Consulting Check out our reading list Download our free startup resources guide to grow your biotech efficiently If you're on the job market, visit the Collaboratory Career Hub

    44 мин.
  7. Building Biotechs Better: Inside LabCentral's Culture of Innovation with Mike LaRhette, Chief Business Officer at LabCentral

    25 СЕНТ.

    Building Biotechs Better: Inside LabCentral's Culture of Innovation with Mike LaRhette, Chief Business Officer at LabCentral

    In this episode, we revisit a fun conversation with Mike LaRhette, Chief Business Officer at LabCentral. Mike outlines the essentials for startups, including funding, lab space, mentorship, and resources. He shares his journey from aspiring architect to an architect of biotech ecosystems, detailing his experiences with MassChallenge and LabCentral. Mike offers insights into the key elements that make thriving ecosystems, like government support, industry collaboration, and a density of entrepreneurs. He also discusses how LabCentral supports startups through challenging markets, diverse talent acquisition, and successful graduations. The episode concludes with a lighthearted look at LabCentral's unique culture and the balance between hard work and fun. Learn about LabCentralConttect: Michael LaRhette - LabCentral Connect with us! Link In with Carina Subscribe here: AppleSpotifyGoogle PodcastRSS feed Learn more about Recruitomics Consulting Check out our reading list Download our free startup resources guide to grow your biotech efficiently If you're on the job market, visit the Collaboratory Career Hub 00:00 Introduction and Episode Overview 00:49 Meet Mike LaRhette: From Architect Aspirations to Ecosystem Builder 01:59 Journey into the Biotech Sector 04:34 A Day in the Life at LabCentral 07:32 The Human Side of Biotech Entrepreneurship 09:55 LabCentral Ignite: Bridging Talent and Opportunity 12:08 Effective Communication Strategies at LabCentral 18:13 Key Elements of a Successful Ecosystem 24:30 Debunking Myths About Entrepreneurs 25:58 Challenges in Post-COVID Event Engagement 26:58 Navigating the Tight Market 28:35 Golden Tickets Program 30:40 Support for New Founders at LabCentral 33:16 Transitioning Out of LabCentral 36:22 Balancing Fun and Seriousness at LabCentral 40:00 Future Directions and Personal Growth 41:49 Favorite Books and Final Thoughts

    47 мин.
  8. How to Build a Lean, Mean Biotech Machine: with Bogdan Knezevic, founder of Kaleidoscope Bio

    10 СЕНТ.

    How to Build a Lean, Mean Biotech Machine: with Bogdan Knezevic, founder of Kaleidoscope Bio

    This week I spoke with Bogdan Knezevic, founder of Kaleidoscope Bio, about optimizing biotech workflows and achieving milestones efficiently. Bogdan shared insights into how his platform helps companies manage research and development processes, reducing operational inefficiencies and saving time, resources, and money. He discussed the importance of setting clear goals, breaking down complex workflows, and avoiding shiny object syndrome (a common ailment among scientists). Bogdan also emphasized the value of keeping teams focused and aligned, leveraging automation, and integrating existing tools to minimize manual work. We explored how to empower teams, balance short-term and long-term goals, and pivot gracefully when needed. Additionally, Bogdan touched on the importance of understanding the true cost of operations and making strategic investments in tools that drive productivity. Exhalation: StoriesGet Bogdan's recommended book! Stories of Your Life and OthersBiotech inflection points framework resource:Biotech fundraising milestones resourceLearn more about Kaleidoscope!Link In with Bogdan! Connect with us! Link In with Carina Subscribe here: AppleSpotifyGoogle PodcastRSS feed Learn more about Recruitomics Consulting Check out our reading list Download our free startup resources guide to grow your biotech efficiently If you're on the job market, visit the Collaboratory Career Hub 00:00 Introduction to Systems and Workflow 01:10 Meet Bogdan Knezevic: From Childhood Dreams to Biotech CEO 02:22 The Frustration and Vision Behind Kaleidoscope Bio 04:01 Use Cases and Value Propositions for Biotech Companies 07:50 Empowering Teams and Setting Priorities 11:38 Balancing Short-Term and Long-Term Goals 18:22 Reducing Operational Overhead and Streamlining Processes 31:07 Common Mistakes and Lessons for Biotech Leaders 36:19 Book Recommendations and Closing Thoughts

    41 мин.
5
из 5
Оценок: 25

Об этом подкасте

From the ground floor to the C-Suite, Building Biotechs offers a behind-the-scenes look into the strategy that goes into launching and scaling successful biotech and life science companies. We talk with biotech executives, founders, HR leaders, and culture builders to learn how they think about growing companies with intention, and discuss the valuable lessons they’ve learned along the way.

Вам может также понравиться

Чтобы прослушивать выпуски с ненормативным контентом, войдите в систему.

Следите за новостями подкаста

Войдите в систему или зарегистрируйтесь, чтобы следить за подкастами, сохранять выпуски и получать последние обновления.

Выберите страну или регион

Африка, Ближний Восток и Индия

Азиатско-Тихоокеанский регион

Европа

Латинская Америка и страны Карибского бассейна

США и Канада